Eaglenos

Pioneering precision health management through innovative diagnostics

Nanjing, China · Founded 2018 · $21.2M raised

Headquarters
Nanjing
Employees
201–500
Founded
2018
Business Model
B2B
Total Funding
$21.2M
Last Round
$21.2M Series AMay 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Eaglenos (南京晶捷生物科技有限公司) is a Nanjing, China-based medical device and diagnostics company founded in 2018, specializing in portable point-of-care testing (POCT) devices and personalized health management products. The company develops electrochemical detection platforms, precision sensor materials, and structural diagnostic systems for both human and veterinary healthcare markets. With over 200 employees, 21+ CE certifications, and 76+ authorized patents, Eaglenos delivers reliable diagnostic devices for clinical, workplace, and consumer health settings globally.

Summary

Eaglenos is a Biotech company based in Nanjing, China, founded in 2018. It has raised $21.2M in total across 1 round, most recently a $21.2M Series A round in May 2023. Investors include 3E Bioventures Capital and Huatai Zijin Investment.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2023
$21.2M

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eaglenos on Indexed.vc
<a href="https://indexed.vc/companies/eaglenos"><img src="https://indexed.vc/api/badge/company/eaglenos" alt="Eaglenos on Indexed.vc" width="260" height="76" /></a>